داروسازی روز دارو
دروز | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 33,570 2.98
Close Price: 33,570
Income Statement
AGM
Interim
2026/08/22 Fiscal Year 2026/03/2012 Month | 2024/07/21 Fiscal Year 2025/03/2012 Month | 2024/07/20 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 8.206 Trillion | 7.929 Trillion | 7.443 Trillion | |
Total Revenues | 8.206 Trillion | 7.929 Trillion | 7.443 Trillion | |
Cost of Goods Sold | 5.232 Trillion | 5.651 Trillion | 5.343 Trillion | |
Gross Profit | 2.974 Trillion | 2.279 Trillion | 2.1 Trillion | |
General & Administrative Expenses | 411.719 Billion | 330.816 Billion | 461.05 Billion | |
Net Operating Income & Expenses | -710.261 Billion | 3.59 Billion | -33.517 Billion | |
Operating Profit (Loss) | 1.852 Trillion | 1.951 Trillion | 1.606 Trillion | |
Profit Before Tax | 272.725 Billion | 15.895 Billion | 39.425 Billion | |
Tax | 43.866 Billion | 2.624 Billion | 2.549 Billion | |
Net Profit (Loss) After Tax | 228.859 Billion | 13.271 Billion | 194.34 Billion | |
Retained Earnings at Beginning of Period | -100.4 Billion | 90.606 Billion | 866.333 Billion | |
Prior-Year Tax | - | - | -157.464 Billion | |
Approved Dividends — Prior Year AGM | - | -20.995 Billion | -55.987 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | - | -699.84 Billion | |
Allocable Profit | 128.459 Billion | 82.882 Billion | 304.846 Billion | |
Legal Reserve | 11.443 Billion | 664 Million | 9.717 Billion | |
Approved Dividends — Current Year | - | - | 20.995 Billion | |
Retained Earnings at End of Period | 117.016 Billion | 82.218 Billion | 274.134 Billion |